These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development and Validation of a Polygenic Risk Score for Stroke in the Chinese Population. Lu X; Niu X; Shen C; Liu F; Liu Z; Huang K; Wang L; Li J; Hu D; Zhao Y; Yang X; Lu F; Liu X; Cao J; Chen S; Li H; Tang W; Ren Z; Yu L; Wu X; Wu X; Li Y; Zhang H; Huang J; Hu Z; Shen H; Willer CJ; Gu D Neurology; 2021 Aug; 97(6):e619-e628. PubMed ID: 34031205 [TBL] [Abstract][Full Text] [Related]
6. Identification of risk loci and a polygenic risk score for lung cancer: a large-scale prospective cohort study in Chinese populations. Dai J; Lv J; Zhu M; Wang Y; Qin N; Ma H; He YQ; Zhang R; Tan W; Fan J; Wang T; Zheng H; Sun Q; Wang L; Huang M; Ge Z; Yu C; Guo Y; Wang TM; Wang J; Xu L; Wu W; Chen L; Bian Z; Walters R; Millwood IY; Li XZ; Wang X; Hung RJ; Christiani DC; Chen H; Wang M; Wang C; Jiang Y; Chen K; Chen Z; Jin G; Wu T; Lin D; Hu Z; Amos CI; Wu C; Wei Q; Jia WH; Li L; Shen H Lancet Respir Med; 2019 Oct; 7(10):881-891. PubMed ID: 31326317 [TBL] [Abstract][Full Text] [Related]
7. Minimal improvement in coronary artery disease risk prediction in Chinese population using polygenic risk scores: evidence from the China Kadoorie Biobank. Yang S; Sun D; Sun Z; Yu C; Guo Y; Si J; Sun D; Pang Y; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Pang Z; Schmidt D; Stevens R; Clarke R; Chen J; Chen Z; Lv J; Li L; Chin Med J (Engl); 2023 Oct; 136(20):2476-2483. PubMed ID: 37200020 [TBL] [Abstract][Full Text] [Related]
9. Validation of Genome-Wide Polygenic Risk Scores for Coronary Artery Disease in French Canadians. Wünnemann F; Sin Lo K; Langford-Avelar A; Busseuil D; Dubé MP; Tardif JC; Lettre G Circ Genom Precis Med; 2019 Jun; 12(6):e002481. PubMed ID: 31184202 [TBL] [Abstract][Full Text] [Related]
10. Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data. Agbaedeng TA; Noubiap JJ; Mofo Mato EP; Chew DP; Figtree GA; Said MA; van der Harst P Atherosclerosis; 2021 Sep; 333():48-55. PubMed ID: 34425527 [TBL] [Abstract][Full Text] [Related]
11. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study. Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J Elife; 2023 Mar; 12():. PubMed ID: 36971353 [TBL] [Abstract][Full Text] [Related]
12. Polygenic Hyperlipidemias and Coronary Artery Disease Risk. Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S; Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731 [TBL] [Abstract][Full Text] [Related]
13. Polygenic risk score improves the accuracy of a clinical risk score for coronary artery disease. King A; Wu L; Deng HW; Shen H; Wu C BMC Med; 2022 Nov; 20(1):385. PubMed ID: 36336692 [TBL] [Abstract][Full Text] [Related]
15. Integration of a polygenic score into guideline-recommended prediction of cardiovascular disease. Li L; Pang S; Starnecker F; Mueller-Myhsok B; Schunkert H Eur Heart J; 2024 May; 45(20):1843-1852. PubMed ID: 38551411 [TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a polygenic risk score for lung cancer in never-smoking women: A large-scale prospective Chinese cohort study. Wei X; Sun D; Gao J; Zhang J; Zhu M; Yu C; Ma Z; Fu Y; Ji C; Pei P; Yang L; Millwood IY; Walters RG; Chen Y; Du H; Jin G; Chen Z; Hu Z; Li L; Shen H; Lv J; Ma H Int J Cancer; 2024 Mar; 154(5):807-815. PubMed ID: 37846649 [TBL] [Abstract][Full Text] [Related]
17. European and US Guideline-Based Statin Eligibility, Genetically Predicted Coronary Artery Disease, and the Risk of Major Coronary Events. Park H; Kim D; You SC; Jang E; Yu HT; Kim TH; Kim DM; Sung JH; Pak HN; Lee MH; Yang PS; Joung B J Am Heart Assoc; 2024 May; 13(9):e032831. PubMed ID: 38639378 [TBL] [Abstract][Full Text] [Related]
18. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults: Implications for Primary Prevention. Inouye M; Abraham G; Nelson CP; Wood AM; Sweeting MJ; Dudbridge F; Lai FY; Kaptoge S; Brozynska M; Wang T; Ye S; Webb TR; Rutter MK; Tzoulaki I; Patel RS; Loos RJF; Keavney B; Hemingway H; Thompson J; Watkins H; Deloukas P; Di Angelantonio E; Butterworth AS; Danesh J; Samani NJ; J Am Coll Cardiol; 2018 Oct; 72(16):1883-1893. PubMed ID: 30309464 [TBL] [Abstract][Full Text] [Related]
19. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial. Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C; Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832 [TBL] [Abstract][Full Text] [Related]
20. Derivation and Validation of Genome-Wide Polygenic Score for Ischemic Heart Failure. Paranjpe I; Tsao NL; De Freitas JK; Judy R; Chaudhary K; Forrest IS; Jaladanki SK; Paranjpe M; Sharma P; ; ; Glicksberg BS; Narula J; Do R; Damrauer SM; Nadkarni GN J Am Heart Assoc; 2021 Nov; 10(22):e021916. PubMed ID: 34713709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]